🇫🇷 Poteligeo in France

Poteligeo (MOGAMULIZUMAB) regulatory status in France.

Marketing authorisation

ANSM

  • Local brand name: Poteligeo
  • Status: approved

Poteligeo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in France

Frequently asked questions

Is Poteligeo approved in France?

Yes. ANSM has authorised it.

Who is the marketing authorisation holder for Poteligeo in France?

Kyowa Kirin is the originator. The local marketing authorisation holder may differ — check the official source linked above.